Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Org Chem ; 89(4): 2787-2793, 2024 Feb 16.
Article in English | MEDLINE | ID: mdl-38301250

ABSTRACT

The reductive Heck hydroarylation of unactivated alkenes has emerged as an essential reaction for regioselective hydroarylation. Herein, we report a palladium-catalyzed reductive Heck hydroarylation of unactivated alkenes under mild conditions with enhanced functional group tolerance using hydrosilane as the reducing reagent. Under the optimal conditions, the alkylarene yields increased, resulting in minimal undesired products. Mechanistic studies using deuterated reagents indicated the involvement of two competing catalytic cycles.

2.
Biochem Biophys Res Commun ; 497(1): 298-304, 2018 02 26.
Article in English | MEDLINE | ID: mdl-29432733

ABSTRACT

Rac1 is a member of the Rho family of small GTPases that regulates cytoskeletal reorganization, membrane polarization, cell migration and proliferation. Recently, a self-activating mutation of Rac1, Rac1P29S, has been identified as a recurrent somatic mutation frequently found in sun-exposed melanomas, which possesses increased inherent GDP/GTP exchange activity and cell transforming ability. However, the role of cellular Rac1-interacting proteins in the transforming potential of Rac1P29S remains unclear. We found that the catalytic domain of DOCK1, a Rac-specific guanine nucleotide exchange factor (GEF) implicated in malignancy of a variety of cancers, can greatly accelerate the GDP/GTP exchange of Rac1P29S. Enforced expression of Rac1P29S induced matrix invasion and macropinocytosis in wild-type (WT) mouse embryonic fibroblasts (MEFs), but not in DOCK1-deficient MEFs. Consistently, a selective inhibitor of DOCK1 that blocks its GEF function suppressed the invasion and macropinocytosis in WT MEFs expressing Rac1P29S. Human melanoma IGR-1 and breast cancer MDA-MB-157 cells harbor Rac1P29S mutation and express DOCK1 endogenously. Genetic inactivation and pharmacological inhibition of DOCK1 suppressed their invasion and macropinocytosis. Taken together, these results indicate that DOCK1 is a critical regulator of the malignant phenotypes induced by Rac1P29S, and suggest that targeting DOCK1 might be an effective approach to treat cancers associated with Rac1P29S mutation.


Subject(s)
Gene Expression Regulation, Neoplastic/genetics , Neoplasms, Experimental/genetics , Neoplasms, Experimental/pathology , Pinocytosis/genetics , rac GTP-Binding Proteins/antagonists & inhibitors , rac1 GTP-Binding Protein/genetics , Cell Line, Tumor , Humans , Mutation/genetics , Neoplasm Invasiveness
3.
RSC Adv ; 14(9): 6121-6126, 2024 Feb 14.
Article in English | MEDLINE | ID: mdl-38375001

ABSTRACT

Tropic acid was synthesized in a good yield and with high enantioselectivity (81% ee) under non-biphasic conditions via the novel hydrolytic dynamic kinetic resolution of racemic 3-phenyl-2-oxetanone (tropic acid ß-lactone) in the presence of a chiral quaternary ammonium phase-transfer catalyst and strongly basic anion exchange resin as the hydroxide ion donor.

4.
J Am Chem Soc ; 135(5): 1688-91, 2013 Feb 06.
Article in English | MEDLINE | ID: mdl-23327446

ABSTRACT

Recent developments in in-cell NMR techniques have allowed us to study proteins in detail inside living eukaryotic cells. In order to complement the existing protocols, and to extend the range of possible applications, we introduce a novel approach for observing in-cell NMR spectra using the sf9 cell/baculovirus system. High-resolution 2D (1)H-(15)N correlation spectra were observed for four model proteins expressed in sf9 cells. Furthermore, 3D triple-resonance NMR spectra of the Streptococcus protein G B1 domain were observed in sf9 cells by using nonlinear sampling to overcome the short lifetime of the samples and the low abundance of the labeled protein. The data were processed with a quantitative maximum entropy algorithm. These were assigned ab initio, yielding approximately 80% of the expected backbone NMR resonances. Well-resolved NOE cross peaks could be identified in the 3D (15)N-separated NOESY spectrum, suggesting that structural analysis of this size of protein will be feasible in sf9 cells.


Subject(s)
Bacterial Proteins/chemistry , Baculoviridae/genetics , Calmodulin/chemistry , Metallochaperones/chemistry , Nuclear Magnetic Resonance, Biomolecular , Spodoptera/virology , Algorithms , Animals , Bacterial Proteins/genetics , Calmodulin/genetics , Cell Line , Copper Transport Proteins , Entropy , Humans , Metallochaperones/genetics , Molecular Chaperones , Quantum Theory , Rats , Sf9 Cells , Thermus thermophilus/genetics
5.
J Infect Chemother ; 17(6): 803-6, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21681500

ABSTRACT

The immunological pathogenesis of Mycoplasma pneumoniae pneumonia is known to involve several cytokines. The serum levels of interleukin-18 (IL-18) were examined using enzyme-linked immunosorbent assay in 23 pediatric patients (median age 6 years; range 4-13 years; 14 girls and 9 boys) with M. pneumoniae pneumonia admitted to our hospital. Serum levels of IL-18 ranged from 22 to 1808 pg/ml with a mean of 543 pg/ml. We started steroid therapy in two cases with IL-18 values greater than 1000 pg/ml without being aware of IL-18 levels. Examination of associations between IL-18 levels determined by enzyme-linked immunosorbent assay and a routine laboratory test showed that levels of lactate dehydrogenase (LDH) and IL-18 were significantly correlated. To determine the appropriateness of steroid administration in M. pneumoniae pneumonia patients, serum LDH should be examined. Patients with elevated levels of LDH are likely to have significantly elevated IL-18 values (≥1000 pg/ml) and thus can be candidates for steroid therapy.


Subject(s)
Interleukin-18/immunology , Mycoplasma pneumoniae/immunology , Pneumonia, Mycoplasma/immunology , Adolescent , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Child , Child, Preschool , Cohort Studies , Enzyme-Linked Immunosorbent Assay , Female , Humans , Interleukin-18/blood , L-Lactate Dehydrogenase/blood , Male , Methylprednisolone/therapeutic use , Pneumonia, Mycoplasma/blood , Pneumonia, Mycoplasma/drug therapy , Pneumonia, Mycoplasma/microbiology
6.
Org Lett ; 20(6): 1593-1596, 2018 03 16.
Article in English | MEDLINE | ID: mdl-29517241

ABSTRACT

We developed 2-position-selective, direct C-H trifluoromethylation, pentafluoroethylation, and heptafluoropropylation of quinoline derivatives. Regioselective transformation was achieved without derivatization of the quinolines. The reaction proceeded at room temperature with high functional group tolerance, even in gram scale. Notably, the reaction was applicable to substrates containing a functional group sensitive to oxidation and a drug molecule.

7.
Clin Nucl Med ; 43(11): 835-836, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30179908

ABSTRACT

Ga-pentixafor is a novel radioligand of C-X-C motif chemokine receptor 4. A 55-year-old woman with a history of primary Sjögren's syndrome underwent Ga-pentixafor PET/CT for staging of lymphoma originating from mucosa-associated lymphoid tissue. Whereas no lymphoma manifestation could be detected, imaging revealed bilateral intense radiotracer uptake in both parotid and submandibular salivary glands, consistent with inflammatory cell infiltration.


Subject(s)
Coordination Complexes , Peptides, Cyclic , Positron Emission Tomography Computed Tomography , Radiopharmaceuticals , Sjogren's Syndrome/diagnostic imaging , Female , Humans , Middle Aged
9.
Cell Rep ; 19(5): 969-980, 2017 05 02.
Article in English | MEDLINE | ID: mdl-28467910

ABSTRACT

Oncogenic Ras plays a key role in cancer initiation but also contributes to malignant phenotypes by stimulating nutrient uptake and promoting invasive migration. Because these latter cellular responses require Rac-mediated remodeling of the actin cytoskeleton, we hypothesized that molecules involved in Rac activation may be valuable targets for cancer therapy. We report that genetic inactivation of the Rac-specific guanine nucleotide exchange factor DOCK1 ablates both macropinocytosis-dependent nutrient uptake and cellular invasion in Ras-transformed cells. By screening chemical libraries, we have identified 1-(2-(3'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)-2-oxoethyl)-5-pyrrolidinylsulfonyl-2(1H)-pyridone (TBOPP) as a selective inhibitor of DOCK1. TBOPP dampened DOCK1-mediated invasion, macropinocytosis, and survival under the condition of glutamine deprivation without impairing the biological functions of the closely related DOCK2 and DOCK5 proteins. Furthermore, TBOPP treatment suppressed cancer metastasis and growth in vivo in mice. Our results demonstrate that selective pharmacological inhibition of DOCK1 could be a therapeutic approach to target cancer cell survival and invasion.


Subject(s)
Antineoplastic Agents/pharmacology , Cell Movement/drug effects , Pyridones/pharmacology , rac GTP-Binding Proteins/adverse effects , Animals , Antineoplastic Agents/therapeutic use , Cell Line, Tumor , Cell Survival/drug effects , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Neoplasms, Experimental/drug therapy , Pinocytosis/drug effects , Pyridones/therapeutic use , Small Molecule Libraries/pharmacology , Small Molecule Libraries/therapeutic use , rac GTP-Binding Proteins/genetics , rac GTP-Binding Proteins/metabolism , ras Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL